Clinical Trials on Primary Peritoneal Transitional Cell Carcinoma
Total 17091 results
-
Centre Hospitalier Universitaire de NīmesSaint-Louis Hospital, Paris, France; Institut Paoli-Calmettes; Center Eugene... and other collaboratorsRecruitingCancer | Urothelial CarcinomaFrance
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedKidney Cancer | Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Shanxi Province Cancer HospitalCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire de NīmesInstitut Bergonié; Institut de cancérologie Strasbourg Europe; Centre Antoine... and other collaboratorsRecruiting
-
Changhai HospitalRenJi Hospital; West China Hospital; Tongji Hospital; Qilu Hospital of Shandong... and other collaboratorsRecruitingUrothelial CarcinomaChina
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
AstraZenecaCompletedUrothelial CarcinomaUnited States
-
Chang Gung Memorial HospitalActive, not recruitingUrothelial CarcinomaTaiwan
-
RemeGen Co., Ltd.CompletedUrothelial CarcinomaChina
-
Shanghai Zhongshan HospitalFudan University; Shanghai Jiao Tong University School of MedicineCompletedUrothelial Carcinoma
-
RemeGen Co., Ltd.Completed
-
The Netherlands Cancer Institute4SC AGActive, not recruitingUrothelial CarcinomaNetherlands
-
Matthew GalskyAstraZenecaActive, not recruitingUrothelial CarcinomaUnited States
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Genentech, Inc.Approved for marketing
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEndo PharmaceuticalsCompletedUrothelial CarcinomaUnited States
-
Rambam Health Care CampusCompleted
-
National Taiwan University HospitalUnknownUrothelial CarcinomaTaiwan
-
China Medical University HospitalUnknown
-
China Medical University HospitalUnknown
-
National Cancer Institute (NCI)Not yet recruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions
-
Hospital del MarUnknownBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerSpain
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerSpain, France, Belgium, Israel, Switzerland, Netherlands, Italy
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
Dr Anders UllénBayer; Pierre Fabre Laboratories; Nordic Urothelial Cancer Oncology GroupCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; University of BernRecruitingAdvanced Urothelial CarcinomaSwitzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMetastatic Urothelial CarcinomaUnited States
-
Brigham and Women's HospitalNot yet recruitingMuscle Invasive Bladder Urothelial CarcinomaUnited States
-
Michael Bau MortensenRecruitingColo-rectal Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Peritoneum CancerDenmark
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Lawrence FongCellSight Technologies, Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
University of MichiganPfizerTerminatedBladder Cancer | Urothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknown
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdNot yet recruitingMuscle-invasive Urothelial CarcinomaJapan
-
Ziekenhuis Oost-LimburgCompletedPseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma; Peritoneum
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Ureter Cancer | Urethral CancerUnited Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerItaly
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerNetherlands
-
Tianjin Medical University Second HospitalRecruiting
-
Novartis PharmaceuticalsCompletedUrothelial CancerUnited States, Spain, Taiwan, Germany, Canada, United Kingdom, Italy, Austria
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
Centre Francois BaclessePfizerRecruiting
-
Associació per a la Recerca Oncologica, SpainPivotal S.L.; Merck, S.L., SpainCompletedMetastatic Urothelial CancerSpain